NYSE:NUS - Nu Skin Enterprises Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$81.75 -0.67 (-0.81 %)
(As of 06/19/2018 04:00 PM ET)
Previous Close$82.42
Today's Range$80.51 - $81.88
52-Week Range$53.50 - $84.00
Volume554,177 shs
Average Volume515,898 shs
Market Capitalization$4.61 billion
P/E Ratio25.31
Dividend Yield1.76%
Beta1.34
Nu Skin Enterprises logoNu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:NUS
CUSIP67018T10
Phone801-345-1000

Debt

Debt-to-Equity Ratio0.13
Current Ratio1.14
Quick Ratio0.75

Price-To-Earnings

Trailing P/E Ratio25.31
Forward P/E Ratio23.03
P/E Growth2.54

Sales & Book Value

Annual Sales$2.28 billion
Price / Sales1.99
Cash Flow$4.6661 per share
Price / Cash17.52
Book Value$13.40 per share
Price / Book6.10

Profitability

EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.74%
Return on Equity25.36%
Return on Assets11.54%

Miscellaneous

Employees4,700
Outstanding Shares55,610,000

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Friday, April 27th. Stockholders of record on Friday, May 25th will be paid a dividend of $0.365 per share on Wednesday, June 13th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend is Thursday, May 24th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings results on Thursday, April, 26th. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.70 by $0.09. The company had revenue of $616 million for the quarter, compared to analysts' expectations of $564.46 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.36%. The company's revenue was up 23.4% compared to the same quarter last year. During the same period last year, the firm posted $0.51 EPS. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Nu Skin Enterprises.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided EPS guidance of $3.73-3.93 for the period, compared to the Thomson Reuters consensus estimate of $3.61. The company issued revenue guidance of $2.51-2.56 billion, compared to the consensus revenue estimate of $2.47 billion.Nu Skin Enterprises also updated its Q2 guidance to $0.91-0.96 EPS.

What price target have analysts set for NUS?

6 brokerages have issued 12 month price objectives for Nu Skin Enterprises' shares. Their forecasts range from $57.00 to $98.00. On average, they expect Nu Skin Enterprises' stock price to reach $76.8333 in the next twelve months. View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin is a premier anti-aging company. The company's anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system. " (6/12/2018)
  • 2. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)

Who are some of Nu Skin Enterprises' key competitors?

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 65)
  • Mr. Ritch N. Wood, CEO & Director (Age 52)
  • Mr. Ryan S. Napierski, Pres (Age 44)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)
  • Mr. D. Matthew Dorny, Exec. VP, Gen. Counsel & Sec. (Age 54)

Has Nu Skin Enterprises been receiving favorable news coverage?

Media stories about NUS stock have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a news sentiment score of 0.03 on Accern's scale. They also gave media headlines about the company an impact score of 44.92 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.90%), JPMorgan Chase & Co. (2.22%), Dimensional Fund Advisors LP (2.17%), Old Mutual Global Investors UK Ltd. (1.33%), Wasatch Advisors Inc. (1.26%) and Prudential Financial Inc. (0.81%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Old Mutual Global Investors UK Ltd., Schroder Investment Management Group, JPMorgan Chase & Co., Robertson Opportunity Capital LLC, Riverhead Capital Management LLC, Chicago Equity Partners LLC and Glen Harbor Capital Management LLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Mackay Shields LLC, OppenheimerFunds Inc., Russell Investments Group Ltd., Schwab Charles Investment Management Inc., Landscape Capital Management L.L.C., Dimensional Fund Advisors LP and New York State Common Retirement Fund. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $81.75.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $4.61 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]


MarketBeat Community Rating for Nu Skin Enterprises (NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  369 (Vote Outperform)
Underperform Votes:  340 (Vote Underperform)
Total Votes:  709
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.